Epidemiological aspects of inhibitor development in hemophilia and strategies of management
(2016) In Expert Opinion on Orphan Drugs 4(2). p.153-168
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1714c5a6-bc5c-45b5-8c6f-8b401ba65169
- author
- Klintman, Jenny LU and Berntorp, Erik LU
- organization
- publishing date
- 2016-01-14
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Expert Opinion on Orphan Drugs
- volume
- 4
- issue
- 2
- pages
- 153 - 168
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:84958123253
- ISSN
- 2167-8707
- DOI
- 10.1517/21678707.2016.1127157
- language
- English
- LU publication?
- yes
- id
- 1714c5a6-bc5c-45b5-8c6f-8b401ba65169
- date added to LUP
- 2018-11-12 06:27:10
- date last changed
- 2022-01-31 06:51:25
@article{1714c5a6-bc5c-45b5-8c6f-8b401ba65169,
author = {{Klintman, Jenny and Berntorp, Erik}},
issn = {{2167-8707}},
language = {{eng}},
month = {{01}},
number = {{2}},
pages = {{153--168}},
publisher = {{Taylor & Francis}},
series = {{Expert Opinion on Orphan Drugs}},
title = {{Epidemiological aspects of inhibitor development in hemophilia and strategies of management}},
url = {{http://dx.doi.org/10.1517/21678707.2016.1127157}},
doi = {{10.1517/21678707.2016.1127157}},
volume = {{4}},
year = {{2016}},
}